Home ArgiNOx Pharmaceuticals

ArgiNOx Pharmaceuticals

In operation
Series C
A biopharmaceutical company
Basic
Enterprise Profile

Basic Information

ArgiNOx Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for cardiovascular diseases. It provides Tilarginine Acetate Injection, which inhibits the production of nitric oxide, for the treatment of cardiogenic shock.
ArgiNOx Pharmaceuticals, Inc.
California,United States of America
unclear
January 01, 2000
--
--

Enterprise Profile

Industrial Sector
Biological Drug Production
Application Scenarios
Concept Biologics Drug Concepts